Technology News and Research

RSS

Bruker to supply customized N8 TITANOS large sample AFM to US Commerce Department's NIST

Bruker today announced that it has been awarded a $1.1 million contract to supply a customized N8 TITANOS™ large sample Atomic Force Microscope (AFM) to the United States Commerce Department's National Institute of Standards and Technology (NIST). The instrument will be used by NIST's Precision Engineering Division (PED) at its Manufacturing Engineering Laboratory, with a main focus on metrology applications which require traceable AFM (T-AFM).

26 Apr 2010

Nanoviricides become registered trademark under USPTO

NanoViricides, Inc., announced today that the mark "nanoviricides" has now become a registered trademark under the US Patents and Trademarks Office. The mark was entered into the "principal register" of trademarks at the USPTO on April 20, 2010.

26 Apr 2010

Intellect Neurosciences completes restructuring of balance sheet

Intellect Neurosciences, Inc., a biopharmaceutical company focused on development of disease-modifying therapeutic agents for Alzheimer's disease, announced today it has completed a restructuring of its balance sheet. The result is the extinguishment of approximately $24 million of aggregate face amount plus accrued interest of debt and preferred stock through the issuance of common stock.

26 Apr 2010

BioSante signs Option Agreement to obtain non-exclusive worldwide license for 2A/Furin technology

BioSante Pharmaceuticals, Inc. today announced that it has entered into an Option Agreement with an undisclosed large multi-national pharmaceutical company to obtain a non-exclusive worldwide license for the use of BioSante's 2A/Furin technology in the expression of antibodies.

26 Apr 2010

SQI Diagnostics signs development agreement with Silliker

SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced that it has entered into a development agreement with Silliker, Inc., a leading internationally accredited company dedicated to improving nutrition, food safety and quality, for the commercialization of a botulism toxin panel that will run on SQI's SQiDman analytical system.

26 Apr 2010

Investment report featuring Imaging3

MicroStockProfit.com announces an investment report featuring Imaging3 Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

26 Apr 2010

Kinetic Concepts introduces V.A.C.Via Therapy System

Kinetic Concepts, Inc. today introduced V.A.C.Via Therapy System, a next-generation negative pressure wound therapy solution that offers clinicians and patients a mobile healing technology with the proven benefits and outcomes of V.A.C. Therapy.

26 Apr 2010

Vitamin selected as agency of record for IZI Medical Products

The boutique design-web-public relations firm Vitamin® announced today its selection as agency of record for IZI Medical Products, a Maryland-based innovator of medical device accessories. Vitamin is providing IZI with retained public relations services for strengthening overall brand and key product awareness. Additionally, Vitamin is handling product naming and product branding, as well as integrated marketing for refreshing IZI's new corporate messaging, tagline and logo.

26 Apr 2010

Ness Technologies announces implementation of Oracle E-Business Suite at Teva Czech Industries

Ness Technologies, Inc., a global provider of information technology solutions and services, announced today the start of an Oracle E-Business Suite implementation at Teva Czech Industries s.r.o., a provider of pharmaceutical products. The new system will handle financial and logistics issues, replacing a current QAD MFG/Pro system.

26 Apr 2010

Pevion Biotech to present positive results of PEV4 RSV vaccine candidate at Vaccine Innovation Meeting

Pevion Biotech, the Swiss vaccine company, today announced that it has successfully completed the preclinical safety and efficacy studies of its RSV vaccine candidate PEV4. The vaccine candidate is a modern subunit vaccine candidate against respiratory syncytial virus (RSV), which is based on a recombinant RSV-F protein formulated with Pevion Biotech's proprietary and market-validated virosome technology platform.

26 Apr 2010

U.S. DOE awards Verenium additional $4.9M for development of cellulosic ethanol biorefinery plants

Verenium Corporation, a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, today announced that it has been awarded an additional $4.9 million from the U.S. Department of Energy (DOE) to fund ongoing activities at its demonstration-scale facility in Jennings, Louisiana.

26 Apr 2010

Mimicking human nervous system for bionic applications can become a reality: Researchers

Mimicking the human nervous system for bionic applications could become a reality with the help of a method developed at Oak Ridge National Laboratory to process carbon nanotubes.

26 Apr 2010

GE Healthcare commits to reduce average energy consumption of ultrasound products by 25%

GE Healthcare, a business unit of General Electric Company, announced today a commitment to reduce the average energy consumption of new ultrasound products by 25 percent by 2012.

26 Apr 2010

Delegates of 2010 CADTH Symposium select Sunnybrook poster as Best Overall Poster

A poster from Sunnybrook Health Sciences Centre entitled "Innovative Technology Conserves Resources and Generates Savings: A Case Study from the Sunnybrook Regional Processing Centre" was voted Best Overall Poster by delegates attending the 2010 CADTH Symposium in Halifax, Nova Scotia.

26 Apr 2010

Symphogen's Sympress II technology demonstrates cost-effective single batch production of rpAb

Symphogen A/S today announced the publication of data in the March 20, 2010 online edition of Molecular Biotechnology by Nielsen LS et al. [epub ahead of print] demonstrating the ability of its Sympress II technology to enable cost-effective production of recombinant polyclonal antibodies (rpAb) and antibody mixtures with batch-to-batch consistency that the Company believes could supply drug product for large indications such as cancer and infectious disease.

26 Apr 2010

University of Bern purchases Sectra's SyMRI software for synthetic MR

Sectra has secured the first order for the software SyMRI Suite from the Institute of Forensic Medicine at the University of Bern. The software will enhance quality in conjunction with virtual autopsies.

26 Apr 2010

Mirina closes Versant led Series A-1 financing

Mirina Corporation, a privately held biotechnology company focused on the generation of novel microRNA (miRNA) therapeutics with improved properties, announced today that it has closed a Series A-1 financing. The round was led by new investor Versant Ventures. Previous investors Alexandria Real Estate Equities, ARCH Venture Partners, OVP Venture Partners and WRF Capital also participated in the round. In conjunction with this financing, Brian Atwood, Managing Director of Versant Ventures, will join the Board of Directors.

26 Apr 2010

Biotage to acquire MIP Technologies

Biotage AB a global leader in tools and technology for medicinal and analytical chemistry, and the owners of MIP Technologies AB today announced that the parties have signed a definitive agreement under which Biotage will acquire all outstanding shares in MIP Technologies, a privately held leading developer of molecularly imprinted polymers (MIPs) and other novel polymers.

26 Apr 2010

FDA clears Osmetech's eSensor Thrombophilia Risk Test

Osmetech, plc today announced that the US Food and Drug Administration (FDA) has cleared the eSensor® Thrombophilia Risk Test (TRT), a multiplexed molecular diagnostic test for four genetic markers associated with thrombosis. The panel includes Factor V Leiden, Factor II Prothrombin, MTHFR 677 and MTHFR 1298 in a single test panel.

26 Apr 2010

WISeKey to present Latin American Digital Identification and Trusted cloud computing landscape at MIT conference

Carlos Moreira, Chairman and Founder of WISeKey, is to unveil his vision and plans towards the region in an address to a selected audience of over 500 entrepreneurs and members of the science community in New England during the traditional MIT Latin Conference to be held this week-end in Cambridge, Massachusetts.

26 Apr 2010

Technology News and Research

Bruker to supply customized N8 TITANOS large sample AFM to US Commerce Department's NIST

Nanoviricides become registered trademark under USPTO

Intellect Neurosciences completes restructuring of balance sheet

BioSante signs Option Agreement to obtain non-exclusive worldwide license for 2A/Furin technology

SQI Diagnostics signs development agreement with Silliker

Investment report featuring Imaging3

Kinetic Concepts introduces V.A.C.Via Therapy System

Vitamin selected as agency of record for IZI Medical Products

Ness Technologies announces implementation of Oracle E-Business Suite at Teva Czech Industries

Pevion Biotech to present positive results of PEV4 RSV vaccine candidate at Vaccine Innovation Meeting

U.S. DOE awards Verenium additional $4.9M for development of cellulosic ethanol biorefinery plants

Mimicking human nervous system for bionic applications can become a reality: Researchers

GE Healthcare commits to reduce average energy consumption of ultrasound products by 25%

Delegates of 2010 CADTH Symposium select Sunnybrook poster as Best Overall Poster

Symphogen's Sympress II technology demonstrates cost-effective single batch production of rpAb

University of Bern purchases Sectra's SyMRI software for synthetic MR

Mirina closes Versant led Series A-1 financing

Biotage to acquire MIP Technologies

FDA clears Osmetech's eSensor Thrombophilia Risk Test

WISeKey to present Latin American Digital Identification and Trusted cloud computing landscape at MIT conference

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News